Clearstead Advisors’s 89bio ETNB Stock Holding History

Clearstead Advisors’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,021	Closed	-$29.7K	–	2906
2025 Q3	$29.7K	Sell	2,021 -243	-11%	-$2.48K	﹤0.01%	1466
2025 Q2	$22.2K	Buy	+2,264	New	+$18.7K	﹤0.01%	1578
2024 Q4	–	Sell	-177	Closed	-$1.31K	–	2120
2024 Q3	$1.31K	Hold	177	–	–	﹤0.01%	1883
2024 Q2	$1.42K	Buy	+177	New	+$1.58K	﹤0.01%	1861

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clearstead Advisors's ETNB Position: Q4 2025 in Review

Clearstead Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 2,021 shares — an estimated $29.7K sold.

Clearstead Advisors first reported a position in ETNB in Q2 2024 and held it in 4 quarters. The position peaked at $29.7K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Clearstead Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Clearstead Advisors sold 2,021 89bio shares in Q4 2025, an estimated $29.7K.
Clearstead Advisors first reported a position in 89bio in Q2 2024 and held it in 4 quarters.
Clearstead Advisors's 89bio position peaked at $29.7K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.